Keiko Kamei
Papers
2
Total Citations
12
H-Index
2
About
Keiko Kamei is a leading surgical oncologist whose research centers on advancing minimally invasive pancreatic surgery, particularly for pancreatic cancer. Her major contributions lie in rigorously evaluating the oncologic safety and comparative effectiveness of laparoscopic and robotic distal pancreatectomy. She is the principal investigator of the landmark JCOG2202 (LAPAN) study, a multi-institutional randomized phase III trial that directly compares minimally invasive distal pancreatectomy (MIDP) with open surgery for pancreatic cancer—a pivotal investigation addressing the critical gap in evidence regarding long-term oncologic outcomes. This work, already garnering 9 citations shortly after publication, underscores her role in shaping global surgical standards. Additionally, her single-center retrospective study (2025, 3 citations) provides an intention-based evaluation of spleen-preserving techniques, offering nuanced insights into robotic versus laparoscopic approaches. Dr. Kamei’s research not only clarifies the benefits of MIDP but also establishes benchmarks for future trials, making her a key figure in the evolution of pancreatic cancer surgery. Her commitment to high-quality, multicenter evidence continues to influence clinical practice and inspire the next generation of surgical researchers.
Research Focus
Key Achievements
Top Papers
- 1
- 2